<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Timing for interruption of a direct oral anticoagulant (DOAC) before and after elective surgery</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Timing for interruption of a direct oral anticoagulant (DOAC) before and after elective surgery</h1>
<div class="graphic"><div class="figure"><div class="ttl">Timing for interruption of a direct oral anticoagulant (DOAC) before and after elective surgery</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">This strategy applies to all DOACs in individuals with normal kidney function (eg, CrCl &gt;50 mL/min) and individuals taking apixaban, edoxaban, or rivaroxaban with CrCl 30 to 50 mL/min. For individuals taking dabigatran who have CrCl of 30 to 50 mL/min, omit an additional dose before the procedure. For any DOAC and a high bleeding risk procedure, it may be reasonable to omit the DOAC for an additional postoperative day (5 days total interruption). Refer to UpToDate for additional details.</div><div class="graphic_footnotes">DOAC: direct oral anticoagulant; CrCl: creatinine clearance.</div><div id="graphicVersion">Graphic 130000 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
